The figures below should tell you much about governments in general. It's from an article mostly about Valeant and it's largest shareholder, hedge fund guru Bill Ackman. We didn't bother to run the total, you can do that on your own. But it's a fair chunk of change.
When you factor in all the others over the period to banks, big oil, etc., it leaves an important question that seemingly never gets answered: Where does all that money go? We think is goes to another one of those categories, Don't ask, don't tell. The chart is from MarketWatch. You can read the story there.
| CompanyTotal | Financial Penalties in Billions | Number of Settlements | External Auditor |
| GlaxoSmithKline PLC | $7.56 | 20 | PwC |
| Pfizer Inc. | $2.96 | 15 | KPMG |
| Johnson & Johnson | $2.33 | 14 | PwC |
| Merck & Co. Inc. | $1.86 | 27 | PwC |
| Abbott Laboratories | $1.82 | 12 | EY |
| Eli Lilly & Co. | $1.71 | 13 | EY |
| Schering-Plough | $1.34 | 7 | PwC |
| AstraZeneca PLC | $0.954 | 7 | PwC |
| Takeda Pharmaceutical Co. Ltd. | $0.875 | 1 | KPMG |
| Novartis AG | $0.793 | 12 | PwC |
| Bristol Meyers Squibb Co. | $0.789 | 12 | Deloitte |
| Mylan NV | $0.707 | 19 | PwC |
| Data Source: Pharmaceutical Industry Criminal and Civil Penalties:An Update published Sept. 27, 2012, and MarketWatch research. Valeant external auditor is PwC. |
http://www.marketwatch.com/story/ackman-says-valeant-regulatory-compliance-no-worse-than-rest-of-pharma-industry-2015-10-30
No comments:
Post a Comment